Phase 1 Study of Mesothelin-ADC
NCT02884726
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
8
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Cancer
Interventions
DRUG:
BMS-986148
Sponsor
Bristol-Myers Squibb